The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.
about
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerContribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the PopulationRecommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients.Inherited Mutations in Women With Ovarian CarcinomaGermline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFamilial breast cancer - targeted therapy in secondary and tertiary preventionA risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsReevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer contextCommon variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study.Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling studyPPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic MutationsNew paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study.Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study.Genetic screening for gynecological cancer: where are we heading?Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.BRCA1 and BRCA2 mutations in ovarian cancer patients from China: ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer.Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene.Monoallelic characteristic-bearing heterozygous L1053X in BRCA2 gene among Sudanese women with breast cancer.Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer PatientsFrequency of germline PALB2 mutations among women with epithelial ovarian cancer.Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.XPAT: a toolkit to conduct cross-platform association studies with heterogeneous sequencing datasets.Inherited mutations in BRCA1 and BRCA2 in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from Malaysia.Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.NIPS, a 3D network-integrated predictor of deleterious protein SAPs, and its application in cancer prognosis.DNA damage repair in ovarian cancer: unlocking the heterogeneity.
P2860
Q26780387-44FCB139-5BA0-4AA4-BD0D-656903BCDB64Q28266112-CDFCA0AA-6D13-4CAA-8ACB-8475A92BCFBAQ30250038-138EBF3D-F2D4-445B-8ED8-4310FE6C3385Q30353433-4D0142C7-1790-4F38-A1E3-2EE37EA206C6Q35114576-816DADDC-F4AA-466F-B6DF-3DACB59DA72CQ35399626-42F56DAB-F832-4D80-9C13-A05D646382AEQ35848518-E794F728-425B-4371-A792-9D06CAD6AB49Q36146953-FCE50EBC-B931-436F-98AB-1153F924653CQ36255665-12EFF306-8D41-4EFB-BB00-EBCCC4C27F52Q36276527-FC060122-BFC7-44DB-B74D-FD89FACC390BQ36902674-F17E4EC3-0F4A-49DF-8D50-B23B70C3F353Q36955208-F41F8F27-28A4-4B21-81C3-B1DCADE8E398Q37353838-5D1790D4-9B4A-4E0F-ADCA-8FDEA92D680BQ37398841-7541DC2E-0959-495F-B58E-8F627A0DF6B9Q37601478-0A81D69B-1586-4527-A036-E3294A57C4DDQ38659935-27B1A3E8-AD80-40A2-965D-2D2EA950BE72Q38711217-828C2727-5C27-44F7-9417-901D88C93EBBQ38972917-64650149-FF6B-4CA3-8FAE-0FB09507FA8AQ40053289-904AF590-7F86-401F-84CA-7E2576D51B64Q40081082-2ADE6FC1-5AD5-40B1-A268-DF963BB8379CQ40316397-5A8AD922-8927-4A90-9D00-B3E254C20C45Q40580115-DBD25A4E-37E6-4297-AE37-6864022B95F5Q41218646-BB516E60-FA49-42BF-B6A2-5E1052527369Q41625837-E5C40EC2-BE6A-4B0B-89E8-94582C07B532Q47222722-24E5808B-9B6B-45B5-90C7-438D29A42C36Q47586106-0EC19BE4-631C-4520-B409-34DBA505A82FQ47828874-D3CA98E9-5FAF-4EBF-B2E4-B0989E374D44Q52584601-02289679-8860-4D68-BCC4-36D5836A6F52Q55399645-F709FABE-7F4B-495A-A5BB-CA3A7C8A46A5
P2860
The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The contribution of deleteriou ...... rian cancer in the population.
@ast
The contribution of deleteriou ...... rian cancer in the population.
@en
type
label
The contribution of deleteriou ...... rian cancer in the population.
@ast
The contribution of deleteriou ...... rian cancer in the population.
@en
prefLabel
The contribution of deleteriou ...... rian cancer in the population.
@ast
The contribution of deleteriou ...... rian cancer in the population.
@en
P2093
P2860
P50
P356
P1476
The contribution of deleteriou ...... rian cancer in the population.
@en
P2093
Brooke L Fridley
Ellen L Goode
Honglin Song
Jennifer Alsop
Jonathan P Tyrer
Mercedes Jimenez-Linan
Mine S Cicek
Patricia Harrington
Simon A Gayther
P2860
P304
P356
10.1093/HMG/DDU172
P577
2014-04-12T00:00:00Z